BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2006
View Archived Issues
VE-465, an Aurora kinase inhibitor, shows promising activity in preclinical tests
Read More
Japanese scientists report on the activity of moAb-216
Read More
Snapshots of newly reported clinical trials in multiple myeloma
Read More
VX-680 active at well-tolerated doses in patients with hematologic malignancies
Read More
Decapeptyl four-month formulation studied in phase III trials
Read More
Pharminox and Schering-Plough partner to discover anticancer therapies
Read More
Novel oral chaperones with potential use in Gaucher's disease
Read More
Enrollment complete in phase IIb study of apricitabine
Read More
Preclinical data support novel targets for neurodegenerative disorders
Read More
Isavuconazole begins phase III trials for invasive systemic fungal infections
Read More
Speedel stops phase III study of SPP-301 in diabetic nephropathy over safety
Read More
MN-221 begins phase II for status asthmaticus
Read More
GSK and Genmab sign worldwide agreement for HuMax-CD20
Read More
Phase I progress for prophylactic subunit vaccine to prevent S. aureus infections
Read More
Recent patents disclose novel therapeutic agents for neurological disorders
Read More
New therapeutic agents for gastrointestinal disorders reported in recent patent literature
Read More
BZL-101 demonstrates antitumor activity in breast cancer patients
Read More
New therapeutic agents for endocrine-related disorders imparted in recent patent literature
Read More
Priority review for Torisel NDA in advanced renal cell carcinoma
Read More
Phase I study evaluates Crucell's AdVac-based malaria vaccine
Read More
TC-2696 begins phase II trial in acute postoperative pain
Read More
TTI-1612 receives U.S. and E.U. orphan drug designations in necrotizing enterocolitis
Read More
Albuferon begins first pivotal phase III trial
Read More
PML reported in lupus patients receiving Rituxan
Read More
Phenoptin demonstrates safety and efficacy in PKU patients
Read More
TH-9507 achieves endpoints in HIV-associated lipodystrophy study
Read More
European CHMP recommends use of Actos with insulin in type 2 diabetes
Read More